FDA Adverse Event Death Summary report: N

IMPELLA

MDR report key: 24686394 · Received March 25, 2026

Report

Report Number
1220648-2026-05898
Event Type
Death
Date Received
March 25, 2026
Date of Event
March 17, 2026
Manufacturer
ABIOMED, INC. - 1220648
Product Code
OZD
UDI-DI
00813502012828
PMA / PMN Number
P140003
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ABIOMED INC OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ABIOMED INC, OR ITS EMPLOYEES, CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 0

H6: UPDATED CODES BASED ON THE RESULTS OF THE INVESTIGATION. H11: UPDATED BASED ON THE RESULTS OF THE INVESTIGATION AND ADDED CLINICAL REVIEW. THE ROOT CAUSE OF THE INJURY WAS UNABLE TO BE DETERMINED DUE TO INSUFFICIENT CLINICAL DETAILS.

Description of Event or Problem · 0

AN IMPELLA 5.5 DEVICE WAS INSERTED SURGICALLY INTO THE RIGHT AXILLARY/SUBCLAVIAN ARTERY IN A 75-YEAR-OLD MALE PATIENT WITH A PAST MEDICAL HISTORY OF A PRIOR CORONARY ARTERY BYPASS GRAFT (CABG), AND CORONARY ARTERY DISEASE (CAD), PRESENTING IN POST-CARDIOTOMY CARDIOGENIC SHOCK (PCCS) AND LOW CARDIAC OUTPUT SYNDROME (LCOS), IN SCAI STAGE E SHOCK, ON AN INTRA-AORTIC BALLOON PUMP, ON MULTIPLE INOTROPES AND VASOPRESSORS, AND ON A VENTILATOR FOR RESPIRATORY SUPPORT, PRIOR TO INITIATION OF SUPPORT. THE IMPELLA WAS INSERTED FOR VENTRICULAR SUPPORT FOR A CARDIOTHORACIC (CT) SURGERY: CABG. WHILE THE PATIENT WAS IN THE INTENSIVE CARE UNIT (ICU), THE PATIENT DEVELOPED A LARGE HEMORRHAGIC STROKE. THE FAMILY WAS AT BEDSIDE TO DETERMINE PLAN OF CARE. MORE THAN ONE MONTH AFTER IMPELLA INSERTION, THE FAMILY WITHDREW CARE, AND THE PATIENT EXPIRED ON SUPPORT. THE IMPELLA FUNCTIONED AT P-8 AT 4.7L/MIN AS INTENDED. HIGH-RISK SURGERIES REQUIRE INTENSE BLOOD THINNERS, INCREASING THE RISK OF BLEEDING. BLEEDING IS ALSO A KNOWN RISK DUE TO THE IMPELLA'S ANTICOAGULATION AND PURGE REQUIREMENTS. HEMORRHAGIC STROKES ARE FREQUENTLY LINKED TO THE NECESSARY USE OF BLOOD THINNERS. THE IMPELLA IS CONSERVATIVELY BEING REPORTED FOR DEATH; HOWEVER, IS UNLIKELY TO HAVE CONTRIBUTED TO THE PATIENT'S DEATH, WHICH WAS MOST LIKELY DUE TO THE CLINICAL CONDITION OF A CRITICALLY ILL PATIENT IN POST-CARDIOTOMY CARDIOGENIC SHOCK AND LOW CARDIAC OUTPUT SYNDROME, COMPLICATED BY STAGE E SHOCK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
533101 IMPELLA TEMPORARY NON-ROLLER TYPE LEFT HEART SUPPORT BLOOD PUMP OZD ABIOMED, INC. - 1220648 2026798079 00813502012828

Patients

Seq Age Sex Outcome Treatment
1 75 YR Male Death